MB, Levis & Associates’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.41K Hold
9
﹤0.01% 227
2026
Q1
$2.32K Hold
9
﹤0.01% 207
2025
Q4
$2.39K Hold
9
﹤0.01% 215
2025
Q3
$2.5K Hold
9
﹤0.01% 213
2025
Q2
$2.85K Hold
9
﹤0.01% 235
2025
Q1
$2.83K Hold
9
﹤0.01% 241
2024
Q4
$2.37K Hold
9
﹤0.01% 255
2024
Q3
$2.96K Buy
9
+1
+13% +$344 ﹤0.01% 248
2024
Q2
$2.81K Hold
8
﹤0.01% 246
2024
Q1
$3.07K Hold
8
﹤0.01% 241
2023
Q4
$2.52K Hold
8
﹤0.01% 242
2023
Q3
$2.4K Hold
8
﹤0.01% 244
2023
Q2
$2.35K Hold
8
﹤0.01% 245
2023
Q1
$2.13K Hold
8
﹤0.01% 247
2022
Q4
$2.74K Buy
+8
New +$2.53K ﹤0.01% 226

Other funds holding CI

MB, Levis & Associates's CI Position: Q2 2026 in Review

MB, Levis & Associates held its Cigna (CI) position steady in Q2 2026 at 9 shares worth $2.41K. The position accounts for ﹤0.01% of the portfolio, ranked #227.

MB, Levis & Associates first reported a position in CI in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.07K in Q1 2024. 476 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • MB, Levis & Associates held 9 shares of Cigna worth $2.41K as of Q2 2026.
  • MB, Levis & Associates left its Cigna share count unchanged in Q2 2026.
  • Cigna made up ﹤0.01% of MB, Levis & Associates's portfolio in Q2 2026, its #227 holding.
  • MB, Levis & Associates first reported a position in Cigna in Q4 2022 and has held it in 15 quarters since.
  • MB, Levis & Associates's Cigna position peaked at $3.07K in Q1 2024.
  • 476 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on MB, Levis & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.